Genomic Aberrations Drive Clonal Evolution of Neuroendocrine Tumors
{{output}}
Molecular features of castration-resistant neuroendocrine prostate cancer (CRPC-NE) are not well characterized. A recent study that investigated genomic aberrations of CRPC-NE tumors suggests their clonal evolution from CRPC adenocarcinoma. Furthermore, the ex... ...
